Drugs / IGE-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01723254 | Dec 2012 → Jun 2015 | allergic rhinitis | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IGE-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01723254 ↗ |
| Modality | Vaccine | “An Anti-ige Vaccine” NCT01723254 ↗ |
| Route | Intramuscular | “Intramuscular, multiple dose” NCT01723254 ↗ |